MCID: WLD002
MIFTS: 56

Waldenstrom Macroglobulinemia malady

Rare diseases, Neuronal diseases, Fetal diseases, Blood diseases, Cancer diseases, Immune diseases categories

Aliases & Classifications for Waldenstrom Macroglobulinemia

About this section
Sources:
30LifeMap Discovery®, 41NIH Rare Diseases, 43Novoseek, 60UMLS, 47Orphanet, 34MESH via Orphanet, 61UMLS via Orphanet, 26ICD10 via Orphanet
See all sources

Waldenstrom Macroglobulinemia, Aliases & Descriptions:

Name: Waldenstrom Macroglobulinemia 30 41 43 60
Thrombocytopenia - Robin Sequence 41 47
Lymphoplasmacytic Lymphoma 41 47
Braddock-Carey Syndrome 41 47
Malignant Lymphoma - Lymphoplasmacytic 60
Macroglobulinemia of Waldenstrom 41
 
Waldenstrom's Macroglobulinaemia 41
Thrombocytopenia Robin Sequence 60
Waldenström Macroglobulinemia 47
Lymphoplasmacytic Immunocytoma 47
Waldenstrom's Syndrome 41


Classifications:



Characteristics (Orphanet epidemiological data):

47
thrombocytopenia - robin sequence:
Prevalence: <1/1000000 (Worldwide); Age of onset: Infancy,Neonatal
lymphoplasmacytic lymphoma:
Inheritance: Multigenic/multifactorial; Prevalence: 1-9/1000000 (Europe),1-9/100000 (France); Age of onset: Adult; Age of death: elderly


External Ids:

Orphanet47 3323, 33226
MESH via Orphanet34 C536898, D008258
UMLS via Orphanet61 C2931364, C0024419
ICD10 via Orphanet26 C88.0

Summaries for Waldenstrom Macroglobulinemia

About this section


NIH Rare Diseases:41 Waldenstrom macroglobulinemia is a chronic, slow-growing lymphoproliferative disorder. it usually affects older adults and is primarily found in the bone marrow, although lymph nodes and the spleen may be involved. affected individuals have a high level of an antibody called immunoglobulin m (igm) in their blood, which can cause thickening of the blood (hyperviscosity). although some individuals initially do not have symptoms and are diagnosed from routine blood work, common symptoms may include weakness, appetite loss and weight loss. other symptoms may include peripheral neuropathy, fever, raynaud's phenomenon, and mental status changes. hyperviscosity of the blood may cause nosebleeds, headaches, dizziness, and blurring or loss of vision. the cause of the condition is not known but environmental, genetic, and viral factors have been suggested. there have been some reports of familial cases suggesting a genetic predisposition. treatment is often reserved for those with symptoms and may include various medications including corticosteroids, alkylating agents, biologic response modifiers and purine analogues. last updated: 10/1/2013

MalaCards based summary: Waldenstrom Macroglobulinemia, also known as thrombocytopenia - robin sequence, is related to cryoglobulinemia and myeloma, and has symptoms including leukemia, abnormal immunoglobulin level and glossoptosis. An important gene associated with Waldenstrom Macroglobulinemia is MYD88 (myeloid differentiation primary response 88), and among its related pathways are Leishmaniasis and Malaria. The drugs thalidomide and cyclophosphamide and the compounds fluorochrome and endotoxin have been mentioned in the context of this disorder. Affiliated tissues include bone, bone marrow and lymph node, and related mouse phenotypes are tumorigenesis and skeleton.

Related Diseases for Waldenstrom Macroglobulinemia

About this section

Diseases related to Waldenstrom Macroglobulinemia via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 70)
idRelated DiseaseScoreTop Affiliating Genes
1cryoglobulinemia31.0CD40LG
2myeloma30.7IGHM, IRF4, CD40LG
3malt lymphoma29.8ZAP70, IRF4, IGHM
4chronic lymphocytic leukemia29.8CD40LG, MS4A1, IGHM, ZAP70
5hodgkin lymphoma29.7ZAP70, IRF4, IGHM, MS4A1
6b-cell lymphomas29.6IGHM, MS4A1, IRF4, ZAP70
7follicular lymphoma29.5ZAP70, MS4A1, IGHM, IRF4
8burkitt lymphoma29.2CD40LG, ZAP70, MS4A1, IRF4, IGHM
9macroglobulinemia11.2
10lymphoplasmacytic lymphoma10.6
11macroglobulinemia, waldenstrom, somatic10.5
12multiple myeloma10.5
13thrombocytopenia robin sequence10.4
14leukemia10.4
15histiocytosis10.3
16aplastic anemia10.3
17hepatitis c10.3
18gamma heavy chain disease10.3
19heavy chain disease10.3
20thrombocytopenia10.3
21agenesis of the corpus callosum10.3
22polycythemia vera10.2
23pulmonary hypertension10.2
24diffuse large b-cell lymphoma10.2
25hematologic cancer10.2
26hepatitis10.2
27mantle cell lymphoma10.2
28retinal vein occlusion10.2
29central retinal vein occlusion10.2
30protein-losing enteropathy10.2
31poems syndrome10.2
32amyloidosis10.2
33colitis10.2
34neuropathy10.2
35pancreatitis10.2
36polycythemia10.2
37retinitis10.2
38eosinophilic colitis10.2
39cryoglobulinemia, familial mixed10.2CD40LG, IGHM
40agammaglobulinemia10.1IGHM, CD40LG
41wiskott-aldrich syndrome10.1
42paroxysmal nocturnal hemoglobinuria10.1
43renal tubular acidosis10.1
44evans' syndrome10.1
45ureteral obstruction10.1
46peliosis hepatis10.1
47neurofibromatosis10.1
48nocardiosis10.1
49polyarteritis nodosa10.1
50cerebritis10.1

Graphical network of the top 20 diseases related to Waldenstrom Macroglobulinemia:



Diseases related to waldenstrom macroglobulinemia

Symptoms for Waldenstrom Macroglobulinemia

About this section

Symptoms:

 47 (show all 75)
  • microcephaly
  • micrognathia/retrognathia/micrognathism/retrognathism
  • broad nasal root
  • anteverted nares/nostrils
  • glossoptosis
  • cleft palate without cleft lip/submucosal cleft palate/bifid uvula
  • enamel anomaly
  • low set ears/posteriorly rotated ears
  • long/large ear
  • conductive deafness/hearing loss
  • camptodactyly of fingers
  • clinodactyly of fingers 1,2,3,4/overlapping fingers
  • hair and scalp anomalies
  • hypotrichosis/atrichia/atrichiasis/scalp hairlessness
  • woolly/frizzy hair
  • respiratory distress/dyspnea/respiratory failure/lung volume reduction
  • corpus callosum/septum pellucidum total/partial agenesis
  • hypotonia
  • thrombocytopenia/thrombopenia
  • short stature/dwarfism/nanism
  • intrauterine growth retardation
  • high forehead
  • upslanted palpebral fissures/mongoloid slanting palpebral fissures
  • pectus excavatum
  • camptodactyly of some fingers
  • clinodactyly of fifth finger
  • anus ectopia/anteposition/malposition
  • congenital cardiac anomaly/malformation/cardiopathy
  • cardiac septal defect
  • structural anomalies of the kidney and the urinary tract
  • oligoamnios
  • antenatal exposure : hormones
  • monoclonal immunoglobulins/gammapathy/dysglobulinemia
  • bone marrow/medullar infiltration
  • hematologic/blood/lymphatic cancer
  • myeloproliferative syndrome/chronic leukemia
  • dizziness
  • normocytic anemia
  • polynuclear cells/neutrophils anomalies/neutropenia
  • gingivorrhagia/gingival bleeding
  • blood hyperviscosity/hypercoagulability
  • pallor
  • proptosis/exophthalmos
  • retinal vascular anomalies/retinal telangiectasia
  • palpebral edema/periorbital edema
  • hearing loss/hypoacusia/deafness
  • cutis marmorata/marbled skin/livedo
  • urticaria
  • purpura/petichiae
  • malabsorption/chronic diarrhea/steatorrhea
  • gastrointestinal bleeding/hemorrhage/hematemesis/melena/rectorrhagia
  • hepatomegaly/liver enlargement (excluding storage disease)
  • splenomegaly
  • abnormal pleura/hydrothorax/pleuresia/pleural effusion/chylothorax
  • lung/pulmonary infiltrates
  • heart/cardiac failure
  • edema of the legs/lower limbs
  • vascularitis/vasculitides/arteritis
  • lymphadenopathy/polyadenopathies
  • renal failure
  • cranial nerves palsy
  • peripheral neuropathy
  • facial pain/cephalalgia/migraine
  • transient cerebral ischemia/stroke
  • motor deficit/trouble
  • ataxia/incoordination/trouble of the equilibrium
  • obnubilation/coma/lethargia/desorientation
  • troubles of memory/amnesia/hypermnesia
  • anorexia
  • immunodeficiency/increased susceptibility to infections/recurrent infections
  • cryoglobulinemia
  • epistaxis/nose bleeding
  • fever/chilling
  • asthenia/fatigue/weakness
  • biological inflammatory syndrome/increased erythrocyte sedimentation rate/crp

HPO human phenotypes related to Waldenstrom Macroglobulinemia:

(show all 66)
id Description Frequency HPO Source Accession
1 leukemia hallmark (90%) HP:0001909
2 abnormal immunoglobulin level hallmark (90%) HP:0010701
3 glossoptosis hallmark (90%) HP:0000162
4 cleft palate hallmark (90%) HP:0000175
5 microcephaly hallmark (90%) HP:0000252
6 micrognathia hallmark (90%) HP:0000347
7 low-set, posteriorly rotated ears hallmark (90%) HP:0000368
8 macrotia hallmark (90%) HP:0000400
9 conductive hearing impairment hallmark (90%) HP:0000405
10 wide nasal bridge hallmark (90%) HP:0000431
11 anteverted nares hallmark (90%) HP:0000463
12 abnormality of dental enamel hallmark (90%) HP:0000682
13 muscular hypotonia hallmark (90%) HP:0001252
14 intrauterine growth retardation hallmark (90%) HP:0001511
15 thrombocytopenia hallmark (90%) HP:0001873
16 respiratory insufficiency hallmark (90%) HP:0002093
17 woolly hair hallmark (90%) HP:0002224
18 short stature hallmark (90%) HP:0004322
19 aplasia/hypoplasia of the corpus callosum hallmark (90%) HP:0007370
20 abnormal hair quantity hallmark (90%) HP:0011362
21 camptodactyly of finger hallmark (90%) HP:0100490
22 gingival bleeding typical (50%) HP:0000225
23 pallor typical (50%) HP:0000980
24 abnormality of neutrophils typical (50%) HP:0001874
25 normocytic anemia typical (50%) HP:0001897
26 respiratory insufficiency typical (50%) HP:0002093
27 vertigo typical (50%) HP:0002321
28 hypercoagulability typical (50%) HP:0100724
29 abnormality of the urinary system typical (50%) HP:0000079
30 high forehead typical (50%) HP:0000348
31 upslanted palpebral fissure typical (50%) HP:0000582
32 pectus excavatum typical (50%) HP:0000767
33 oligohydramnios typical (50%) HP:0001562
34 abnormality of the cardiac septa typical (50%) HP:0001671
35 clinodactyly of the 5th finger typical (50%) HP:0004209
36 ectopic anus typical (50%) HP:0004397
37 camptodactyly of finger typical (50%) HP:0100490
38 renal insufficiency occasional (7.5%) HP:0000083
39 hearing impairment occasional (7.5%) HP:0000365
40 epistaxis occasional (7.5%) HP:0000421
41 proptosis occasional (7.5%) HP:0000520
42 cutis marmorata occasional (7.5%) HP:0000965
43 urticaria occasional (7.5%) HP:0001025
44 congestive heart failure occasional (7.5%) HP:0001635
45 splenomegaly occasional (7.5%) HP:0001744
46 subcutaneous hemorrhage occasional (7.5%) HP:0001933
47 malabsorption occasional (7.5%) HP:0002024
48 anorexia occasional (7.5%) HP:0002039
49 migraine occasional (7.5%) HP:0002076
50 abnormality of the pleura occasional (7.5%) HP:0002103
51 pulmonary infiltrates occasional (7.5%) HP:0002113
52 gastrointestinal hemorrhage occasional (7.5%) HP:0002239
53 hepatomegaly occasional (7.5%) HP:0002240
54 incoordination occasional (7.5%) HP:0002311
55 memory impairment occasional (7.5%) HP:0002354
56 vasculitis occasional (7.5%) HP:0002633
57 cerebral ischemia occasional (7.5%) HP:0002637
58 lymphadenopathy occasional (7.5%) HP:0002716
59 abnormality of temperature regulation occasional (7.5%) HP:0004370
60 reduced consciousness/confusion occasional (7.5%) HP:0004372
61 cranial nerve paralysis occasional (7.5%) HP:0006824
62 abnormality of the retinal vasculature occasional (7.5%) HP:0008046
63 peripheral neuropathy occasional (7.5%) HP:0009830
64 edema of the lower limbs occasional (7.5%) HP:0010741
65 periorbital edema occasional (7.5%) HP:0100539
66 cryoglobulinemia occasional (7.5%) HP:0100778

Drugs & Therapeutics for Waldenstrom Macroglobulinemia

About this section

Drug clinical trials:

Search ClinicalTrials for Waldenstrom Macroglobulinemia

Search NIH Clinical Center for Waldenstrom Macroglobulinemia

Inferred drug relations via UMLS60/NDF-RT39:

Cell-based therapeutics:


LifeMap Discovery
Data from LifeMap, the Embryonic Development and Stem Cells Database
Read about Waldenstrom Macroglobulinemia cell therapies at LifeMap Discovery.

Genetic Tests for Waldenstrom Macroglobulinemia

About this section

Anatomical Context for Waldenstrom Macroglobulinemia

About this section

MalaCards organs/tissues related to Waldenstrom Macroglobulinemia:

31
Bone, Bone marrow, Lymph node, Spleen, Heart, Lung, Neutrophil, B cells, Kidney, Liver, Skin, T cells

Animal Models for Waldenstrom Macroglobulinemia or affiliated genes

About this section

MGI Mouse Phenotypes related to Waldenstrom Macroglobulinemia:

35
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00020068.8IRF4, MYD88, IGHM
2MP:00053908.3IGHM, MYD88, ZAP70, CD40LG
3MP:00053977.2CD40LG, ZAP70, MS4A1, IRF4, MYD88, IGHM
4MP:00053877.1IGHM, MYD88, IRF4, MS4A1, ZAP70, CD40LG

Publications for Waldenstrom Macroglobulinemia

About this section

Articles related to Waldenstrom Macroglobulinemia:

(show top 50)    (show all 111)
idTitleAuthorsYear
1
Cyclophosphamide, bortezomib and dexamethasone (CyBorD) combination in Waldenstrom Macroglobulinemia. (25703132)
2015
2
Targeting survival and cell trafficking in multiple myeloma and Waldenstrom macroglobulinemia using pan-class I PI3K inhibitor, buparlisib. (25060991)
2014
3
Characterization of subpopulation lacking both B-cell and plasma cell markers in Waldenstrom macroglobulinemia cell line. (24189269)
2014
4
Long-term results of the phase II trial of the oral mTOR inhibitor everolimus (RAD001) in relapsed or refractory Waldenstrom Macroglobulinemia. (24716234)
2014
5
Waldenstrom macroglobulinemia presenting as isolated persistent epistaxis: a very rare presentation. (24427564)
2013
6
A single-arm, phase II study of the anti-Blys monoclonal antibody belimumab in symptomatic Waldenstrom macroglobulinemia. (23773449)
2013
7
Nuclear protein dysregulation in lymphoplasmacytic lymphoma/waldenstrom macroglobulinemia. (23355206)
2013
8
Genome wide SNP array identified multiple mechanisms of genetic changes in Waldenstrom macroglobulinemia. (23861223)
2013
9
Primary therapy of Waldenstrom macroglobulinemia (WM) with weekly bortezomib, low-dose dexamethasone, and rituximab (BDR): long-term results of a phase 2 study of the European Myeloma Network (EMN). (24004667)
2013
10
Clinical and prognostic implications of low or high level of von Willebrand factor in patients with Waldenstrom macroglobulinemia. (22896002)
2012
11
IL-21 in the bone marrow microenvironment contributes to IgM secretion and proliferation of malignant cells in Waldenstrom macroglobulinemia. (22976953)
2012
12
Fludarabine plus cyclophosphamide and rituximab in Waldenstrom macroglobulinemia: an effective but myelosuppressive regimen to be offered to patients with advanced disease. (21732338)
2012
13
Waldenstrom macroglobulinemia with a durable clinical response to epoetin beta. (22260157)
2012
14
Concomitant Waldenstrom macroglobulinemia and IgA plasmablastic myeloma in a patient with untreated IgM paraproteinemia: sequential development of biclonal B-cell neoplasms over a 10-year period in a single individual. (22404949)
2012
15
FGFR3 is overexpressed waldenstrom macroglobulinemia and its inhibition by Dovitinib induces apoptosis and overcomes stroma-induced proliferation. (21521775)
2011
16
Residual monotypic plasma cells in patients with waldenstrom macroglobulinemia after therapy. (21350089)
2011
17
The role of serum immunoglobulin free light chain in response and progression in waldenstrom macroglobulinemia. (21415221)
2011
18
Hyperphosphorylated paratarg-7: a new molecularly defined risk factor for monoclonal gammopathy of undetermined significance of the IgM type and Waldenstrom macroglobulinemia. (21220746)
2011
19
Successful treatment of eosinophilic colitis by montelukast sodium plus budesonide in a patient with Waldenstrom macroglobulinemia. (21575902)
2011
20
New insights into the pathogenesis and treatment of Waldenstrom macroglobulinemia. (21519243)
2011
21
The bone marrow microenvironment in waldenstrom macroglobulinemia. (23556094)
2011
22
Dual targeting of the PI3K/Akt/mTOR pathway as an antitumor strategy in Waldenstrom macroglobulinemia. (19965685)
2010
23
microRNA-dependent modulation of histone acetylation in Waldenstrom macroglobulinemia. (20519629)
2010
24
Selective inhibition of chymotrypsin-like activity of the immunoproteasome and constitutive proteasome in Waldenstrom macroglobulinemia. (20110419)
2010
25
Phase II trial of weekly bortezomib in combination with rituximab in relapsed or relapsed and refractory Waldenstrom macroglobulinemia. (20142586)
2010
26
High-dose therapy and autologous stem-cell transplantation in Waldenstrom macroglobulinemia: the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation. (20368570)
2010
27
Successful treatment with rituximab and thalidomide of POEMS syndrome associated with Waldenstrom macroglobulinemia. (20673674)
2010
28
Review of clinical trials conducted in Waldenstrom macroglobulinemia and recommendations for reporting clinical trial responses in these patients. (20795787)
2010
29
Immune-related and inflammatory conditions and risk of lymphoplasmacytic lymphoma or Waldenstrom macroglobulinemia. (20181958)
2010
30
Expression of regulatory genes for lymphoplasmacytic cell differentiation in Waldenstrom Macroglobulinemia. (19220283)
2009
31
International prognostic scoring system for Waldenstrom macroglobulinemia. (19196866)
2009
32
Simultaneously significant hepatic and mild splenic uptake of Tc-99m MDP resulting from Waldenstrom macroglobulinemia. (19542951)
2009
33
SDF-1/CXCR4 and VLA-4 interaction regulates homing in Waldenstrom macroglobulinemia. (18448868)
2008
34
Risk of lymphoproliferative disorders among first-degree relatives of lymphoplasmacytic lymphoma/Waldenstrom macroglobulinemia patients: a population-based study in Sweden. (18703425)
2008
35
Inherited and acquired variations in the hyaluronan synthase 1 (HAS1) gene may contribute to disease progression in multiple myeloma and Waldenstrom macroglobulinemia. (18815290)
2008
36
Development of EBV-associated diffuse large B-cell lymphoma in Waldenstrom macroglobulinemia and mantle cell lymphoma. (18608870)
2008
37
Irreversible visual loss and optic nerve dysfunction associated with central retinal vein occlusion in Waldenstrom Macroglobulinemia. (18551947)
2007
38
Recognizing hyperviscosity syndrome in patients with Waldenstrom macroglobulinemia. (17441400)
2007
39
Intestinal lymphangiectasia with protein-losing enteropathy in Waldenstrom macroglobulinemia. (17632262)
2007
40
Proteomic analysis of waldenstrom macroglobulinemia. (17440091)
2007
41
The Akt pathway regulates survival and homing in Waldenstrom macroglobulinemia. (17761832)
2007
42
Analysis of 6q deletion in Waldenstrom macroglobulinemia. (17655703)
2007
43
B-lymphocyte stimulator (BLyS) stimulates immunoglobulin production and malignant B-cell growth in Waldenstrom macroglobulinemia. (16304043)
2006
44
Impaired class switch recombination (CSR) in Waldenstrom macroglobulinemia (WM) despite apparently normal CSR machinery. (16317092)
2006
45
Treatment of 72 newly diagnosed Waldenstrom macroglobulinemia cases with oral melphalan, cyclophosphamide, and prednisone: results and cost analysis. (15611977)
2005
46
Lymphoplasmacytic lymphoma/waldenstrom macroglobulinemia: an evolving concept. (16210920)
2005
47
Initial immunoglobulin M 'flare' after rituximab therapy in patients diagnosed with Waldenstrom macroglobulinemia: an Eastern Cooperative Oncology Group Study. (15493038)
2004
48
A case of t(8;14) with total and partial trisomy 3 in Waldenstrom macroglobulinemia. (9595048)
1998
49
Treatment of Waldenstrom macroglobulinemia with 2-chlorodeoxyadenosine. (8093333)
1993
50
Pulmonary manifestations of Waldenstrom macroglobulinemia. (6776807)
1980

Variations for Waldenstrom Macroglobulinemia

About this section

Expression for genes affiliated with Waldenstrom Macroglobulinemia

About this section
Search GEO for disease gene expression data for Waldenstrom Macroglobulinemia.

Pathways for genes affiliated with Waldenstrom Macroglobulinemia

About this section

Pathways related to Waldenstrom Macroglobulinemia according to GeneCards Suite gene sharing:

(show all 15)
idSuper pathways (with members indented)ScoreTop Affiliating Genes
1
Show member pathways
9.6CD40LG, MYD88
29.6CD40LG, MYD88
39.6ZAP70, MYD88
49.5ZAP70, IGHM
5
Show member pathways
Immune response T cell receptor signaling pathway58
Immune response CD28 signaling58
Immune response ICOS pathway in T helper cell58
9.5IGHM, ZAP70
69.4CD40LG, ZAP70
79.4ZAP70, CD40LG
89.3IRF4, MYD88
9
Show member pathways
9.3IRF4, MYD88
10
Show member pathways
Apoptosis Modulation and Signaling36
Apoptosis36
9.3IRF4, MYD88
119.1IRF4, CD40LG
12
Show member pathways
Calcium signaling in the CD4+ TCR pathway36
9.1CD40LG, IRF4
139.1CD40LG, ZAP70, MYD88
14
Show member pathways
9.0CD40LG, ZAP70, IGHM
15
Show member pathways
BCR signaling pathway36
TCR Signaling Pathway36
8.6CD40LG, ZAP70, IRF4

Compounds for genes affiliated with Waldenstrom Macroglobulinemia

About this section
Sources:
43Novoseek, 24HMDB, 12DrugBank, 49PharmGKB
See all sources

Compounds related to Waldenstrom Macroglobulinemia according to GeneCards Suite gene sharing:

idCompoundScoreTop Affiliating Genes
1fluorochrome439.6CD40LG, ZAP70
2endotoxin439.6CD40LG, MYD88
3hyaluronic acid43 2410.5CD40LG, HAS1
4okt3439.5CD40LG, ZAP70
5cytidine43 24 1211.5ZAP70, CD40LG
6formaldehyde43 2410.3CD40LG, ZAP70
7cyclophosphamide43 49 1211.0ZAP70, MS4A1
8fludarabine43 49 1211.0CD40LG, ZAP70, MS4A1
9rituximab43 49 1211.0MS4A1, ZAP70, CD40LG

GO Terms for genes affiliated with Waldenstrom Macroglobulinemia

About this section

Cellular components related to Waldenstrom Macroglobulinemia according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1plasma membraneGO:00058868.2CD40LG, ZAP70, MYD88, IGHM, HAS1

Biological processes related to Waldenstrom Macroglobulinemia according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1B cell proliferationGO:00421009.2CD40LG, MS4A1
2adaptive immune responseGO:00022509.2ZAP70, IGHM
3T cell activationGO:00421109.1ZAP70, IRF4

Products for genes affiliated with Waldenstrom Macroglobulinemia

About this section
  • Antibodies
  • Proteins
  • Lysates
  • Antibodies
  • Proteins
  • Kits and Assays

Sources for Waldenstrom Macroglobulinemia

About this section
3CDC
13ExPASy
14FMA
22GTR
23HGMD
24HMDB
25ICD10
26ICD10 via Orphanet
27ICD9CM
28IUPHAR
29KEGG
33MeSH
34MESH via Orphanet
35MGI
38NCIt
39NDF-RT
42NINDS
43Novoseek
45OMIM
46OMIM via Orphanet
50PubMed
51QIAGEN
56SNOMED-CT via Orphanet
60UMLS
61UMLS via Orphanet